BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18941220)

  • 1. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
    Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
    J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.
    Sharma D; Bastard K; Guethlein LA; Norman PJ; Yawata N; Yawata M; Pando M; Thananchai H; Dong T; Rowland-Jones S; Brodsky FM; Parham P
    J Immunol; 2009 Oct; 183(7):4569-82. PubMed ID: 19752231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
    Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
    J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules.
    Fadda L; O'Connor GM; Kumar S; Piechocka-Trocha A; Gardiner CM; Carrington M; McVicar DW; Altfeld M
    J Virol; 2011 Jun; 85(12):5970-4. PubMed ID: 21471246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.
    Taner SB; Pando MJ; Roberts A; Schellekens J; Marsh SG; Malmberg KJ; Parham P; Brodsky FM
    J Immunol; 2011 Jan; 186(1):62-72. PubMed ID: 21115737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
    O'Connor GM; Vivian JP; Widjaja JM; Bridgeman JS; Gostick E; Lafont BA; Anderson SK; Price DA; Brooks AG; Rossjohn J; McVicar DW
    J Immunol; 2014 Mar; 192(6):2875-84. PubMed ID: 24563253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
    Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
    J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
    Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
    J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
    Lutz CT
    Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.
    Grifoni A; Montesano C; Patronov A; Colizzi V; Amicosante M
    Biomed Res Int; 2013; 2013():283805. PubMed ID: 23984333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
    Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
    Front Immunol; 2018; 9():1855. PubMed ID: 30147699
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA alleles determine differences in human natural killer cell responsiveness and potency.
    Kim S; Sunwoo JB; Yang L; Choi T; Song YJ; French AR; Vlahiotis A; Piccirillo JF; Cella M; Colonna M; Mohanakumar T; Hsu KC; Dupont B; Yokoyama WM
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3053-8. PubMed ID: 18287063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
    Vyas Y; Selvakumar A; Steffens U; Dupont B
    Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
    Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
    Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
    Stern M; Ruggeri L; Capanni M; Mancusi A; Velardi A
    Blood; 2008 Aug; 112(3):708-10. PubMed ID: 18502829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.